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OBJECTIVE: To compare the effects of weight loss on visceral and subcutaneous abdominal fat, liver and pancreas lipid content
and to test the effects of these changes on metabolic improvement observed after weight loss.
DESIGN: Weight-loss program designed to achieve a loss of 7--10% of the initial weight.
SUBJECTS: 24 obese subjects (13 males and 11 females) with age ranging from 26 to 69 years and body mass index (BMI)
30.2--50.5kgm
 2. Measurements: weight, BMI, waist circumference, body composition as assessed by dual-energy X-ray
absorptiometry, metabolic variables, leptin, adiponectin, visceral and subcutaneous abdominal fat, liver and pancreas lipid
content as assessed by magnetic resonance were evaluated before and after weight loss achieved by hypocaloric diet.
RESULTS: After a mean body weight decrease of 8.9%, BMI, waist circumference, fat mass, all metabolic variables, homeostasis
model assessment of insulin resistance (HOMA), alanine amino transferase, gamma glutamyl transpeptidase, high-sensitivity
C-reactive protein (hs-CRP) and leptin, but not adiponectin and high-density lipoprotein-cholesterol, signiﬁcantly decreased (all
Po0.01). Visceral and subcutaneos abdominal fat, liver and pancreas lipid content signiﬁcantly decreased (all Po0.01). Percent
changes in liver lipid content were greater (84.1±3%) than those in lipid pancreas content (42.3±29%) and visceral abdominal
fat (31.9±15.6%). After weight loss, percentage of subjects with liver steatosis decreased from 75 to 12.5%. Insulin resistance
improvement was predicted by changes in liver lipid content independently of changes in visceral fat, pancreas lipid content,
systemic inﬂammation, leptin and gender.
CONCLUSION: Moderate weight loss determines signiﬁcant decline in visceral abdominal fat, lipid content in liver and
pancreas. Reduction of liver lipid content was greater than that of pancreas lipid content and visceral fat loss. Liver lipid
content is the strongest predictor of insulin resistance improvement after weight loss.
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INTRODUCTION
Several studies showed that even moderate weight loss improves
metabolic complications of obesity.
1,2 This may be due to a
preferential loss of visceral fat compared with subcutaneous
3,4 or
may also be due to a reduction in the ectopic fat content.
5- -9 In
fact, it has been demonstrated that ectopic fat deposition
(i.e., liver, pancreas and muscle fat inﬁltration) signiﬁcantly
contributes to insulin resistance and metabolic alterations
observed in obese subjects.
6,7 Recently, in a murine model it has
been shown that impairment of glucose homeostasis and insulin
resistance are associated with hepatosteatosis
9 and triglyceride
overaccumulation in the pancreas,
10 consequent to long-term
high-fat feeding. Using computed tomography at the midthigh
level, a signiﬁcant decrease in muscle lipid content after moderate
weight loss has been observed in obese sedentary subjects.
5,6,8
Using magnetic resonance, Colles et al.
11 observed a signiﬁcant
decline in liver volume, a proxy of liver fat inﬁltration, after a mean
weight loss of 10% in obese subjects. In eight obese subjects with
type 2 diabetes, Peterson et al.
12 observed that a weight loss of
8kg normalized fasting glucose and that this improvement was
associated with an 81% decline of intrahepatic lipid content.
To the best of our knowledge, no studies have evaluated the
effect of weight loss on pancreas lipid content in obese people or
the possible contribution of its decrease to the metabolic
improvement observed after weight loss. Furthermore, no studies
compared the relative simultaneous decline in liver and pancreas
ectopic fat deposition after weight loss.
The aim of this study was to compare the effect of weight loss
on visceral and subcutaneous abdominal fat and on liver and
pancreas fat content. A further aim was to test the combined and
separate effects of these simultaneous declines on metabolic
improvement. Magnetic resonance, considered the gold standard
for assessment of body composition,
13 was used to quantify
visceral and subcutaneous adipose tissue as well as liver and
pancreas lipid content before and after weight loss.
MATERIALS AND METHODS
Subjects
A total of 24 subjects (13 men and 11 women) with mean age 46.7±14.3
years and mean body mass index (BMI) 35.4±4.5kgm
 2, were included in
the study. All subjects were in good general health, as determined by a
complete medical history and physical examination, as well as a normal
blood count, chemical screening battery and urine analysis except for
obesity, hypercholesterolemia (42.8%), hypertension (35.7%). No patients
had previously diagnosed diabetes according to American Diabetes
Association,
14 21.4% were smokers. Subjects with fasting plasma glucose
X7m Ml
 1 (two men and one woman) were excluded from the study as
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for women.
15 All women were post-menopausal and not on hormonal
replacement therapy. None of the participants was regularly engaged in
physical activity or changed his physical activity level during the study. All
participants gave their informed consent and the experimental protocol
was approved by the Ethical Committee of our University.
Anthropometric measurements
With the subjects wearing light indoor clothes and no shoes, body weight
was measured to the nearest 0.1kg. (Salus scale, Milan, Italy), and height to
the nearest 0.5cm using a stadiometer (Salus stadiometer). BMI was
calculated as body weight adjusted by stature squared (kgm
 2). Waist
circumference was obtained with a measuring tape as the minimum
circumference between the xyphoid process and the umbilicus.
Body composition assessment
Body composition was measured using dual-energy X-ray absorptiometry
(Hologic QDR 4500, Waltham, MA, USA) array beam System Software
Version 11.1.
The characteristics and physical concepts of dual-energy X-ray
absorptiometry measurement have been described elsewhere.
16 Daily
quality-assurance tests were performed according to the manufacturer’s
directions. All scans were subsequently analyzed by a single trained
investigator. Total body fat was expressed in kg (fat mass) and as a
percentage of body weight (fat mass %).
Magnetic resonance data acquisition
MRI (magnetic resonance imaging) was performed with a 1.5T magnet
(Symphony, Siemens Medical Systems, Erlangen, Germany) and two body
phased-array coils. The imaging protocol included an axial T1-weighted
dual-phase gradient-echo sequence (repetition time ms/echo time ms,
96/2.33 (opposed phase), 96/4.85 (in phase); ﬂip angle 701; matrix
320 320; ﬁeld of view 500cm) of the upper abdomen and an axial T1-
weighted gradient-echo sequence (TR 90; TE 3.46; ﬂip angle 701; matrix
256 256; ﬁeld of view 500cm) from L3 to L5. APR and GAZ rated the
quality of all MR images on a scale of 1 to 5 (5 being optimal signal to noise
ratio, 1 being unreadable) as previously described.
17 The average MR
quality was 4.1 (ranging from 3 to 5).
Abdominal fat evaluation
All images were analyzed using Sliceomatic image analysis software
(version 4.2, Tomovision, Montreal, Canada) and a single reader measured
visceral adipose tissue (AT) and subcutaneous AT on a single slice at L4- -L5
for men and women, as previously described.
13
Abdominal subcutaneous AT area was deﬁned as the area of adipose
tissue between the skin and the outermost aspect of the abdominal
muscle wall. All the adipose tissue pixels within the abdominal cavity
between the innermost aspect of the abdominal and oblique wall
musculature and the anterior aspect of the vertebral body were considered
visceral abdominal AT. Interclass correlations for intra-reader comparisons
in a subgroup of 20 subjects were 0.996 for subcutaneous AT, 0.993 for
visceral AT.
Ectopic fat inﬁltration evaluation
MR images were reviewed on a commercially available workstation
(Leonardo, Siemens Medical Systems) by a single reader who was unaware
of laboratory and clinical results.
The technique used to measure SI (signal intensity) values from regions
of interest (ROIs) in the liver and spleen and to calculate the relative SI
losses of the liver and the other organs was based on methods previously
described for the liver.
18 The percentage of relative SI loss on opposed-
phase MR images was considered to be a reasonable measurement of liver
fat on the basis of the known effect of fat on SI values. The SI values of the
liver and spleen were recorded on in- and opposed-phase T1-weighted MR
images by positioning circular ROIs at anatomically matched locations on
paired sequences, avoiding visible vessels, abnormalities and artefacts.
Three circular ROIs were positioned in the liver (left lobe, upper right lobe
and lower right lobe), three in the pancreas (head, body and tail, avoiding
the main pancreatic duct), one each in the psoas muscles. The s.d. of the SI
measurements within each ROI was kept to less than 10%. The SI of the
spleen was similarly measured by positioning two circular ROIs in the
splenic parenchyma. Size of the ROI was variable in the different organs:
1- -2cm diameter for the liver and spleen, equal or smaller for the pancreas.
When more than one ROI was positioned in an organ, a mean SI was
calculated to account for signal heterogeneity.
Liver fat was estimated on opposed-phase MR images as the percentage
of relative SI loss of the liver on opposed-phase images with a previously
used formula
18
RSID ¼ 100  ð Lin=Sin   Lop=SopÞ=ðLin=SinÞ
where Lin is in-phase mean liver SI, Sin is mean in-phase spleen SI, Lop is
mean opposed-phase liver SI and Sop is mean opposed-phase spleen SI.
Similar formulas were used to calculate the amount of fat in the
pancreas according to previous reports.
17,19,20 The grading system for liver
steatosis was based on that used in earlier studies:
21,22 grade 0
corresponding to less than 5% steatosis; grade 1 to 6- -33% steatosis;
grade 2 to 34--66% steatosis; and grade 3 to greater than 66% steatosis.
The grading system incorporates the accepted normal value of histo-
pathological liver fat, which is less than 5%, and is the standard applied in
the clinical assessment of severity of liver steatosis. We calculated the intra-
and inter-observer variability of our MRI measurements for pancreatic fat
content and liver fat content, which were 8.2% and 9.7% and 7.8% and
8.2%, respectively (as determined in a subset of 20 obese patients).
17
Biochemical analyses
Venous blood samples for all metabolic assessments were obtained after
overnight fast. Plasma glucose was measured using a glucose analyzer
(Beckman Instruments Inc., Palo Alto, CA, USA). The intra-assay coefﬁcient
of variation was 1.5%.
Plasma immune-reactive insulin underwent duplicate measurements by
double-antibody radioimmunoassay using a commercial kit (Diagnostic
Products Corp., Los Angeles, CA, USA). Sensitivity was 6pMl
 1 and the
intra-assay coefﬁcient of variation was 4.9%.
Insulin resistance was estimated with the HOMA (homeostasis model
assessment of insulin resistance) method.
23
Cholesterol and triglyceride levels were determined using a Technicon
Auto analyzer (Technicon Inc., Co, Tarrytown, NY, USA) and dextran-
magnesium precipitation was used to separate high-density lipoprotein.
Serum leptin was measured using a speciﬁc ELISA kit (DBC-Diagnostic
Biochem Canada Inc., London, Canada). Sensitivity was 0.5ngml
 1 and the
intra-assay and interassay coefﬁcient of variations were 7.4% and 9.6%,
respectively.
Serum adiponectin was measured with a commercially available ELISA
kit (B-Bridge International, Inc., Sunnyvale, CA, USA). Sensitivity was
20pgml
 1 and the intra-assay and interassay coefﬁcient of variations were
3.5% and 5.2%, respectively.
Dietary intake
A trained dietician performed a 7-day dietary recall interview in order to
assess the dietary habits of each subject enrolled in the study. A recall grid
representing 7 days of the prior week and all possible food-encounter
times was used by the dietician. Portion sizes were estimated for foods and
ﬂuids by comparing with reference foods and ﬂuids in a booklet of
photographs. The interview takes approximately 40min, on average, for
the study subject to complete. The record data were then processed by the
dietician using special software to calculate daily intake of energy, protein,
fat, carbohydrate and alcohol based on the tables furnished by the Italian
National Institute of Nutrition.
24
Hypoenergetic diet
All the subjects completed a weight-loss program designed to achieve a
loss of 7- -10% of the initial weight. The caloric restriction was 500kcal
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and multiplied by a physical activity level of 1.4. Each subject received a
diet providing 62% carbohydrates, 24% fat, 14% protein and 20g ﬁber. The
only beverage allowed was water. The subjects underwent monthly clinical
and nutritional follow-ups. Dietary compliance was checked by a 24-h
recall every 4 weeks during an outpatient visit.
Statistical analyses
Results are shown as means±s.d. Log transformations were performed for
non-normal variables. Comparisons of anthropometric, metabolic and
body-composition variables before and after weight loss were made by
using paired t-test. Mcnemar test was used to test changes in the
prevalence of liver steatosis before and after weight loss. Correlation
analyses were used to test associations between variables. Linear
regression analyses were used to test the joint effects of changes in liver
and pancreas lipid content, as well as changes in leptin, high-sensitivity
C-reactive protein (hs-CRP), visceral AT and waist circumference after
weight loss on HOMA changes. The level of statistical signiﬁcance was
Po0.05 for all the variables. All statistical analyses were performed using
the SPSS statistical package.
25
RESULTS
The ﬂowchart of study participants is shown in Figure 1.
Anthropometric, body composition, fat distribution, hs-CRP,
adipokines and metabolic variables before and after weight loss
are shown in Table 1. The mean decrease in body weight was
8.9%. BMI and waist circumference signiﬁcantly decreased after
weight loss (both Po0.001) as well as fat mass and fat mass %
(both Po0.001). Visceral, subcutaneous and total abdominal AT
signiﬁcantly decreased (all Po0.001). Among the metabolic
variables, glucose, insulin, HOMA, total cholesterol, triglycerides
and leptin signiﬁcantly decreased (all Po0.01), whereas adipo-
nectin did not change. A signiﬁcant decline was also observed in
gamma glutamyl transpeptidase and alanine amino transferase
(both Po0.001).
Changes in liver and pancreas lipid content in each of the
subjects enrolled in the study expressed as mean±s.d. values are
shown in Figures 2a and b. Liver lipid content signiﬁcantly
41 subjects (20 men and 21 women)
underwent clinical
assessment at baseline
38 subjects
(18 men and 20 women)
underwent diet intervention
14 subjects lost at follow-up:
10 subjects didn’t achieved the >7%
weight loss 
1 low quality MRI at follow-up
3 lost to follow-up
76 subjects BMI>30
36 men and 40 women
were assessed for eligibility
3 subjects (2 men and
1 women) excluded for
previously undiagnosed
Type 2 Diabetes 
24 subjects (13 men and 11 women)
3-6 months follow-up
evaluation after >7% weight loss 
35 subjects excluded:
11 declined to participate
17 alcohol intake over 20/30 g/day
7 adherence issues
Figure 1. Flowchart of participant recruitment, screening and
assessment.
Table 1. Anthropometric, body composition, fat distribution, metabolic variables, Hs-CRP and adipokines variables before and after weight loss
Variables Baseline
mean±s.d.
N¼24 (M/F:13/11)
After weight loss
mean±s.d.
N¼24 (M/F:13/11)
Percentage change (%) P
Weight (kg) 98.4±15.9 89.7±14.8  8.88 o0.001
BMI (kgm
 2) 35.4±4.5 32.2±4.0  9.04 o0.001
Waist circumference (cm) 105.4±12.3 98.6±10.6  6.04 o0.001
Fat mass (kg) 35.3±6.9 29.6±6.1  16.1 o0.001
Fat mass percent (%) 36.4±6.2 33.5±6.4  7.96 o0.001
Fat-free mass (kg) 63.1±7.9 60.1±7.2  4.71 o0.001
Total abdominal AT (cm
2) 574.3±154.1 464.5±135.7  19.1 o0.001
Subcutaneous abdominal AT (cm
2) 399.9±124.4 345.5±114.1  13.6 o0.001
Visceral abdominal AT (cm
2) 174.8±94.7 118.9±76.3  31.9 o0.001
Liver lipid content (%) 20.9±25.4 3.3±7.5  84.1 o0.001
Pancreas lipid content (%) 19.7±23.3 11.3±14.3  42.3 ¼0.001
Glucose (mMl
 1) 5.1±0.6 4.9±0.6  0.37 ¼0.01
Insulin (mUIml
 1) 14.9±7.8 9.1±4.3  39.1 o0.001
HOMA 3.35±1.6 1.98±0.9  40.9 o0.001
Total cholesterol (mMl
 1) 5.43±1.1 4.93±0.8  9.2 ¼0.002
HDL cholesterol (mMl
 1) 1.23±0.4 1.29±0.4 4.8 ¼0.06
Triglycerides (mMl
 1) 1.63±0.86 1.19±0.52  26.99 ¼0.01
Gamma GT (UIl
 1) 27.79±19.8 19.33±17.00  30.4 o0.001
ALT (UIl
 1) 37.25±23.09 28.46±17.48  23.6 o0.001
Leptin (ngml
 1) 32.95±20.24 20.88±16.04  36.6 o0.001
Adiponectin (mgdl
 1) 15.12±8.58 15.70±8.90 3.8 ¼0.316
Hs-CRP (mgl
 1) 5.55±6.28 3.48±3.30 37.3 ¼0.005
Abbreviations: ALT, alanine amino transferase; AT, adipose tissue; BMI, body mass index; Gamma GT, gamma glutamyl transpeptidase; HDL, high-density
lipoprotein; HOMA, Homeostasis Model Assessment of insulin resistance; Hs-CRP, high-sensitivity C-reactive protein.
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P¼0.001, respectively). Interestingly, percent changes in liver
lipid content were greater (84.1±3%) than those in pancreas lipid
content (42.3±29%), visceral abdominal AT (31.9±15.6%)
and subcutaneous abdominal AT (13.6±25.9%).
As far as hepatic steatosis, as assessed by MRI, 75% (18/24)
patients showed steatosis at baseline: respectively 50% (12/24)
grade 1 steatosis, 12.5% (3/24) grade 2 steatosis and 12.5% (3/24)
grade 3 steatosis. After weight loss, the percentage of subjects
with steatosis signiﬁcantly decreased to 12.5% (P¼0.008) and
none of these subjects had grade 2 or 3 steatosis (Figure 3).
Table 2 shows the correlations between changes in anthropo-
metric variables, body composition, biochemical variables and
changes in liver and pancreas lipid content and HOMA index after
weight loss.
The loss of liver lipid content was related with the decrease in
visceral AT (r¼0.664, Po0.001), subcutaneous AT (r¼0.505,
P¼0.012) and hs-CRP (r¼0.554, P¼0.005). Pancreas lipid
inﬁltration decrease was related to visceral AT decrement after
weight loss (Po0.001). An association between the respective
changes in the liver and pancreas lipid content was also observed
(P¼0.033).
HOMA improvement was associated with reduction in waist
circumference, visceral and subcutaneous abdominal AT and
change in hs-CRP and insulin.
To evaluate independent determinants of insulin resistance
improvement, a linear regression analysis was performed
considering changes in HOMA index as dependent variable and
the variables most closely correlated with it as independent variables.
Table 3 shows different models considering gender, changes in liver
and pancreas lipid content, visceral AT (or alternatively waist), leptin
and hs-CRP as determinants of HOMA improvement.
The proportion of variance explained by gender and change in
liver lipid content was 55%. When change in waist was added,
65.3% of variance was explained. When change in hs-CRP was also
included in the model, a further increase in the proportion of
variance was observed (71.9%) and F-test value decreased to
12.138. Building a model considering gender, changes in liver lipid
content, visceral AT and hs-CRP as independent variables, 62.9%
of variance in liver lipid content was explained.
A 49.7% and 49.1% of variance was explained, respectively,
building models using gender and waist or alternatively gender
and visceral AT.
DISCUSSION
Our study shows that a moderate weight loss reduces visceral AT as
well as hepatic and pancreatic lipid content. After weight loss,
percent changes are greater in liver lipid content than in pancreas
lipid content and visceral abdominal AT. Furthermore, insulin
resistance, hs-CRP and leptin were signiﬁcantly reduced after
Liver lipid content
0
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Baseline After weight loss
%
p<0.001
Pancreas lipid content
0
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40
60
80
100
Baseline After weight loss 
%
p=0.001
Figure 2. Liver lipid (a) and pancreas lipid (b) content at baseline
and after weight loss.
0%
20%
40%
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80%
100%
Baseline After weight loss
Grade 0 Grade 1 Grade 2 Grade 3
Figure 3. Prevalence of hepatic steatosis before and after weight loss.
Table 2. Correlations between anthropometric, fat distribution, liver and pancreas lipid content measured with magnetic resonance and
biochemical variables changes after weight loss
D body
Weight
D body mass
index
D waist
circumference
D visceral
abdominal AT
D subcutaneous
abdominal AT
D liver lipid
content
D pancreas
lipid content
D Insulin 0.56** 0.41 0.53** 0.37 0.24 0.32 0.09
D Glucose 0.01  0.11  0.14 0.22 0.37 0.09 0.26
D HOMA 0.50*** 0.32 0.63** 0.67* 0.43*** 0.68* 0.32
D Total cholesterol 0.29 0.17  0.21 0.06  0.02  0.22  0.07
D HDL cholesterol  0.04  0.00  0.11  0.18  0.11  0.17 0.17
D Triglycerides 0.12  0.06 0.04 0.32 0.14 0.10 0.03
D hs-CRP 0.33 0.16 0.23 0.54** 0.38 0.55** 0.22
D Adiponectin  0.10  0.34 0.03 0.33  0.03 0.08 0.19
D Leptin 0.11  0.04 0.02  0.13 0.44*** 0.09 0.00
Abbreviations: AT, adipose tissue; HOMA, homeostasis model assessment; hsCRP, high-sensitivity C-reactive protein; Sample size,n¼24. *Po0.001, **Po0.01,
***Po0.05.
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of insulin resistance improvement after weight loss independently
of changes in visceral fat distribution, pancreas lipid content, leptin,
systemic inﬂammation as evaluated with hs-CRP and gender.
As expected, in agreement with previous studies,
4,26 after
weight loss the amount of visceral abdominal AT loss was higher
than that of subcutaneous abdominal AT. Preferential loss of
visceral abdominal AT during initial modest weight loss, due to its
higher lipolysis response, has been reported.
26
After moderate weight loss, we also observed a signiﬁcant loss
in all ectopic fat compartments in our subjects. The decrease in
liver lipid content after weight loss has been previously reported
in patients with type 2 diabetes,
12,27 overweight
28 and obese.
29,30
Interestingly, a decline in body fat % of about 3 units (from 36.4 to
33.5, Table 1), as in our study, has been shown to be associated with
a much greater decline in liver lipid content and with a nearly total
disappearance of liver steatosis. In fact, in our study sample, 75% of
subjects had liver steatosis, as estimated according to Bahl et al.
22 by
liver SI losses higher than 3%, at the beginning of the study and only
12.5% still had after weight loss, thus suggesting that a moderate
weight loss is a landmark treatment for this condition.
To the best of our knowledge, no studies have evaluated
changes in pancreas lipid content after weight loss. Our study
shows a more than 40% reduction of pancreas lipid content after a
moderate weight loss. Pancreas lipid content raises great interest
because it has been suggested that fat deposition in and around
pancreatic islets could be associated with impaired beta cells
function in humans.
31,32 However, its decrease after moderate
weight loss, as reported in our subjects, could contribute to the
improvement of insulin resistance following weight loss.
Our data support that even moderate weight loss may decrease
ectopic fat deposition in both, liver and pancreas, and that the
amount of the decline in each compartment may be different.
In fact, in our study group, mean changes in liver lipid content
were greater than those in pancreas lipid content as well as than
in visceral abdominal AT. Our ﬁndings of greatest decline in liver
lipid content are at least partially in line with those of Colles
et al.,
11 who demonstrated that intra-hepatic fat was mobilized
faster than visceral and subcutaneous fat and with those of
others.
8,12,27- -29 Actually, our results seem to complement and
expand these previous ﬁndings by also giving information on the
effects of weight loss on pancreas lipid content.
Excess liver and pancreas lipid content have been shown to be
frequently present in the same patients: Lee et al.
33 showed that
concurrence of fatty pancreas and fatty liver, as estimated by
sonography, was found in 70% of subjects and fatty liver without
fatty pancreas just in 2%. However, our ﬁndings seem to suggest
that dietary restriction may mobilize more ectopic fat stored in the
liver than in the pancreas.
It has been recently observed, by using immuno-histochemistry,
that fat in human pancreas could be stored in adipocytes between
pancreatic cells in addition to vacuoles in pancreatic cells.
34
No similar evidence has been shown in liver where fat is located
inside hepatic cells; thus our ﬁndings of a higher decline of lipid
content in liver than in pancreas could be at least partially
explained by the fact that weight loss may easily mobilize
triglycerides located inside pancreatic or hepatic cells than those
located inside adipocytes between pancreatic cells.
As expected, in line with previous studies, a moderate weight
loss improved all metabolic variables.
2- -4,6 Insulin resistance, as
estimated by HOMA index, was signiﬁcantly improved after
weight loss in our subjects.
Insulin resistance could result from the contribution of visceral
fat through increased ﬂux of free fatty acids to the liver
35 or by the
activity of some adipokines, such as leptin and adiponectin
36 or by
intracellular fatty acid metabolism through activation of serine
kinase cascade.
37 In agreement with some
6 but not all studies,
38,39
adiponectin levels were not modiﬁed by moderate weight loss in
our subjects, thus adiponectin changes did not seems to have a
major role at least in our study in causing the observed
improvement of insulin resistance.
On the contrary, it is possible to hypothesize that the signiﬁcant
changes in liver, pancreatic fat content, visceral AT and leptin,
observed after weight loss could be all associated with the
improvement in insulin resistance.
To test the joint effects of changes in liver and pancreas lipid
content, fat distribution, leptin and hs-CRP after weight loss
on HOMA improvement we performed a step-down multiple
Table 3. Different linear regression analysis enter method considering D HOMA as the dependent variable and gender, liver lipid content, pancreas
lipid content, VAT, or alternatively waist circumference, leptin and hs-CRP as independent variables
Variables entered in the models Total R
2 b coefﬁcient t Signiﬁcance F
1- -- Gender 0.554 0.332 2.090 0.049 13.069
D liver lipid content 0.548 3.455 0.002
2- -- Gender 0.653 0.219 1.453 0.162 12.535
D liver lipid content 0.448 2.992 0.007
D waist circumference 0.360 2.380 0.027
3- -- Gender 0.719 0.168 1.189 0.249 12.138
D liver lipid content 0.290 1.843 0.081
D waist circumference 0.373 2.662 0.015
D Hs-CRP 0.313 2.110 0.048
1- -- Gender 0.554 0.332 2.090 0.049 13.069
D liver lipid content 0.548 3.455 0.002
2- -- Gender 0.585 0.242 1.944 0.066 9.408
D liver lipid content 0.412 2.857 0.010
D VAT 0.259  0.162 0.873
3- -- Gender 0.629 0.227 1.346 0.194 8.062
D liver lipid content 0.320 1.624 0.121
D VAT 0.188 0.889 0.385
D Hs-CRP 0.262 1.502 0.150
1- -- Gender 0.497 0.343 2.011 0.057 10.390
D waist circumference 0.488 2.862 0.009
1- -- Gender 0.491 0.258 1.380 0.182 10.114
D VAT 0.523 2.794 0.011
Abbreviations: HOMA, homeostasis model assessment; hs-CRP, high-sensitivity C-reactive protein; VAT, visceral adipose tissue.
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dently associated with HOMA improvement.
Changes in liver lipid content together with gender explained in
our study 55.4% of the variance of insulin resistance improvement
after weight loss, independently of visceral fat and pancreas lipid
content decrease. This ﬁnding seems to be in line with recent
observations that increased fat accumulation in liver is the main
determinant of peripheral and hepatic insulin resistance
40 as well
as with the ﬁndings that early and major decrease in liver fat after
weight loss occurs at the same time of normalization of hepatic
insulin sensitivity and fall of glucose levels.
41
Some limitations of our study should be recognized. First, the
relatively small study sample size. Further, although MR spectro-
scopy has been used in the majority of studies that evaluated liver
lipid content before and after weight loss, we used the MR
chemical shift technique. However, high accuracy for the
quantiﬁcation of liver lipid content, validated also against
histological determined percentage of fat,
22 and pancreas lipid
content
20 has been recently reported for this technique. Moreover,
it has been recently shown that in/opposed phase technique is a
valid and reliable tool for both, hepatic and pancreatic fat
quantiﬁcation, showing good agreement with fat-selective spec-
tral-spatial gradient-echo imaging
20,42,43 and also with magnetic
resonance spectroscopy.
44 MR spectroscopy still lacks general
availability in current clinical practice, and the analysis can be
performed only on one voxel at a time. On the contrary, MRI scan
using T1-weighted gradient-echo in-phase and opposed-phase
sequence is a rapid and available technique, already routinely
included in MR-imaging protocols for the upper abdomen.
Moreover, the analysis can be performed on whole organs, and
not on single voxels.
Finally, we only evaluated a surrogate marker of insulin
resistance such as HOMA index and then we were not able
to evaluate hepatic insulin resistance. Thus, it is possible to
speculate that our results could be even more relevant if more
sophisticated methods tailored to test hepatic insulin resistance
were used.
In conclusion, our data show that a moderate weight loss
determines a signiﬁcant decline in visceral abdominal fat, together
with a decline in lipid fat content inside liver and pancreas. After
weight loss percent changes are greater in liver than in pancreas lipid
content and in visceral abdominal AT. Finally, changes in liver lipid
content seem to be the most important predictor of insulin
resistance improvement after weight loss. These results have clinical
implications showing that even a small weight loss is able to reduce
ectopic fat deposition in different splanchnic districts (liver and
pancreas) and this reduction is signiﬁcantly related to relevant
metabolic improvements and showed that moderate weight loss is a
cornerstone treatment of liver steatosis in obese people.
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